Key result
Selective non-adrenergic modulation may enhance adipocyte browning and thermogenesis while minimizing systemic adverse effects.
Why the study?
Effective strategies to safely enhance human brown adipose tissue thermogenic capacity are lacking, as traditional beta-adrenergic stimulation causes systemic adverse effects.
Non-adrenergic receptor signaling pathways offer a potential therapeutic strategy to safely enhance brown adipocyte thermogenic capacity for metabolic diseases.
Answers are grounded in this paper and cite their sources.
May enable safer thermogenic therapies for metabolic disease; leaves open prospective human trials to confirm efficacy.
Brown adipose tissue (BAT) is increasingly recognized as a metabolically active organ in adult humans that contributes to systemic energy homeostasis and represents a potential therapeutic target for obesity-associated metabolic diseases. However, effective strategies to increase BAT mass or thermogenic activity in humans have not yet been established. Although β-adrenergic receptors have traditionally been viewed as the principal drivers of adaptive thermogenesis and adipocyte browning, β-adrenergic stimulation alone may be insufficient to safely enhance BAT thermogenic capacity due to systemic adverse effects. Emerging evidence suggests that alternative receptor-mediated signaling pathways contribute to the regulation of brown adipocyte function, including both UCP1-dependent and UCP1-independent thermogenic mechanisms, and systemic metabolic homeostasis. These pathways include G protein-coupled receptors, receptor tyrosine kinases, and nuclear receptors, which enable brown adipocytes to integrate endocrine, immune, nutritional, and thermal cues. In this review, we discuss recently characterized non-adrenergic receptor signaling pathways and their potential roles in regulating adipocyte browning and thermogenic activity in human adipose tissues. This review highlights the concept of selective modulation of non-adrenergic receptor signaling as a strategy to enhance adipocyte browning and thermogenic capacity while minimizing systemic adverse effects. Understanding these integrated signaling networks may facilitate the development of safer and more selective therapeutic strategies targeting brown adipocyte function in metabolic disease.
No takes yet. Share an insight, caveat, or question.
Yukimasa Takeda (2026) conducted a review in Obesity-associated metabolic diseases. Non-adrenergic receptor signaling modulation was evaluated. Selective modulation of non-adrenergic receptor signaling pathways may enhance adipocyte browning and thermogenic capacity while minimizing systemic adverse effects.
Synapse has enriched 10 related papers. Consider them for comparative context: